TY  - GEN
AU  - Huleatt,Paul B
AU  - Khoo,Mui Ling
AU  - Chua,Yi Yuan
AU  - Tan,Tiong Wei
AU  - Liew,Rou Shen
AU  - Balogh,Balázs
AU  - Deme,Ruth
AU  - Gölöncsér,Flóra
AU  - Magyar,Kalman
AU  - Sheela,David P
AU  - Ho,Han Kiat
AU  - Sperlágh,Beáta
AU  - Mátyus,Péter
AU  - Chai,Christina L L
TI  - Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease
SN  - 1520-4804
PY  - 2015///0414
KW  - Animals
KW  - Cell Survival
KW  - drug effects
KW  - Cells, Cultured
KW  - Dose-Response Relationship, Drug
KW  - Humans
KW  - Mice
KW  - Molecular Structure
KW  - Monoamine Oxidase
KW  - metabolism
KW  - Monoamine Oxidase Inhibitors
KW  - chemical synthesis
KW  - Neuroprotective Agents
KW  - PC12 Cells
KW  - Pargyline
KW  - analogs & derivatives
KW  - Parkinson Disease
KW  - drug therapy
KW  - Propylamines
KW  - Rats
KW  - Structure-Activity Relationship
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1021/jm501722s
ER  -